Table of Contents
Executive Summary
7
SWOT Analysis8
Australia Pharmaceuticals And Healthcare Industry SWOT 8
Australia Political SWOT 9
Australia Economic SWOT Analysis 10
Australia Business Environment SWOT 10
Pharmaceutical Business Environment Ratings 11
Table: Asia Pharmaceuticals Business Environment Ratings 11
Limits of Potential Returns 12
Risks to Realisation of Returns 12
Australia - Market Summary14
Regulatory Regime16
Table: Priorities Of the Therapeutic Goods Administrations Strategic Plan, 2006-2008 16
OTC Switching Climate 17
Regional Regulatory Harmonisation 18
Recent Regulatory Developments 19
Intellectual Property Issues 20
Trade Agreements 21
Pricing and Reimbursement 22
Table: Historical PBS Co-payments 23
Price Cuts 24
Additions to Reimbursed Drugs List 25
Products Added To The PBS In November 2007 26
Table Some Recent Additions to PBS 27
Recent Pricing and Reimbursement Developments 27
Table New PBS Formularies 28
Table: Examples Of Drugs In The New PBS Formularies Classification, September 2007 29
Industry Trends and Developments30
Epidemiology 30
Mental Health Issues 32
Healthcare Reforms 33
E-Health 35
Healthcare Expenditure 35
Prescribing Patterns 36
Table Number of prescribed medications 2006-7 38
Private Healthcare Insurance 38
Domestic Pharmaceutical Sector 39
Recent Domestic Sector Developments 39
Foreign Industry 42
Recent Foreign Sector Developments 43
Retail Pharmacy Sector 44
Biotechnology and Research 45
Table: Australian Biotech Industry Facts 47
Recent Biotechnology Developments 48
Clinical Trials 50
Medical Devices 51
Table Examples Of Medical Devices Classifications 51
Recent Developments in the Medical Devices Sector 52
Industry Forecast Scenario 54
Overall Market Forecast 54
Table: Australia - Drug Expenditure Indicators, Historical Data and Forecasts, 2003-2013 55
Key Growth Factors - Industry 56
Table: Australia - Health Expenditure Indicators, Historical Data and Forecasts, 2003-2013 57
Key Growth Factors - Macroeconomic 58
Table: Australia - Economic Activity, 2006-2013 60
Prescription Market Forecast 61
Table: Australia - Prescription Market Indicators, Historical Data and Forecasts (AUDmn unless otherwise stated) 62
Patented Drug Market Forecast 63
Table: Australia - Patented Market Data And Forecasts, Historical Data and Forecasts, 2003-2013 63
Generics Market Forecasts 64
Table: Australia - Generics Market Indicators, Historical Data and Forecasts, 2003-2013 65
OTC Market Forecast 66
Table: Australia - OTC Market Indicators, Historical Data and Forecasts (AUDmn unless otherwise stated) 67
Pharmaceutical Trade Forecasts 68
Table: Australia - Pharmaceutical Trade Indicators, Historical Data and Forecasts, 2003-2013 (US$mn) 69
Other Healthcare Data Forecasts 69
Table: Australia - Other Healthcare Data And Forecasts, Historical Data and Forecasts, 2003-2013 70
Key Risks to BMI' s Forecast Scenario 70
Competitive Landscape71
Pharmacy Over-The-Counter Medicine Sales In Australia (US$) 2007 72
Company Profiles73
Leading Multinationals 73
Pfizer 73
Sanofi-Aventis 76
GlaxoSmithKline 79
Merck Sharp & Dohme (Australia) 82
Novartis 85
Roche 87
AstraZeneca 90
Eli Lilly 92
Indigenous Manufacturers 95
Sigma Pharmaceuticals 95
Australian Pharmaceutical Industries 98
Alphapharm (incorporated into Mylan) 101
Herron Pharmaceuticals 103
Mayne Pharma (Hospira) 105
Country Snapshot: Australia Demographic Data 107
Section 1: Population 107
Table: Demographic Indicators, 2005-2030 107
Table: Rural/Urban Breakdown, 2005-2012 108
Section 2: Education and Healthcare 108
Table: Education, 2002-2005 108
Table: Vital Statistics 108
Section 3: Labour Market and Spending Power 109
Table: Employment Indicators, 2001-2006 109
Table: Consumer Expenditure, 2000-2012 (US$) 109
Table: Average Annual Wages, 2000-2012 110
BMI Forecast Modelling111
How We Generate Our Pharmaceutical Industry Forecasts 111
Pharmaceutical Business Environment Ratings Methodology 112
Ratings Overview 112
Table: Pharmaceutical Business Environment Indicators 113
Weighting 114
Table: Weighting Of Components 114
Sources 114
| 
View Cart
